California Public Employees Retirement System
SPRO icon

California Public Employees Retirement System’s Spero Therapeutics SPRO Stock Holding History

California Public Employees Retirement System’s Portfolio SPRO Stock Details SPRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-30,600
Closed -$450K – 2740
2021
Q1 		$450K Hold
30,600
– – ﹤0.01% 3016
2020
Q4 		$593K Sell
30,600
-2,694
-8% -$42K ﹤0.01% 2811
2020
Q3 		$372K Buy
33,294
+4,194
+14% +$49.6K ﹤0.01% 2959
2020
Q2 		$394K Buy
+29,100
New +$327K ﹤0.01% 2839
2018
Q2 		– Sell
-25,000
Closed -$356K – 3325
2018
Q1 		$356K Hold
25,000
– – ﹤0.01% 2772
2017
Q4 		$294K Buy
+25,000
New +$307K ﹤0.01% 2863

Other funds holding SPRO

ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

California Public Employees Retirement System's SPRO Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Spero Therapeutics (SPRO) in Q2 2021, closing a stake of 30,600 shares — an estimated $450K sold.

California Public Employees Retirement System first reported a position in SPRO in Q4 2017 and held it in 6 quarters. The position peaked at $593K in Q4 2020. 88 funds tracked by Wall St. Rank hold SPRO as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Spero Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 30,600 Spero Therapeutics shares in Q2 2021, an estimated $450K.
  • California Public Employees Retirement System first reported a position in Spero Therapeutics in Q4 2017 and held it in 6 quarters.
  • California Public Employees Retirement System's Spero Therapeutics position peaked at $593K in Q4 2020.
  • 88 funds tracked by Wall St. Rank held Spero Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.